Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human ...

Recursion will also receive an additional $30 million upfront payment from Bayer to develop new treatments for chronic scar tissue, or fibrotic, diseases of the lung, kidneys and heart.

Recursion Pharmaceuticals dropped for a third straight day on Wednesday, slashing 6.29 percent to close at $4.77 apiece after investors mimicked the recent selling of three company executives.

According to data compiled by S&P Global Market Intelligence, Recursion Pharmaceuticals (NASDAQ: RXRX) stock was shedding more than 17% of its value week-to-date as of Thursday night.

Explore RXRX's upcoming H2'25 trial updates for REC-4881 in familial adenomatous polyposis and REC-617.

Find annual and quearterly earnings data for Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) including earnings per share, earnings forecasts at Nasdaq.com.

Lior Ron, the entrepreneur who founded and ran Uber Technologies Inc.’s freight and logistics unit, is returning to the world of self-driving big rigs.

Football for All kid reporter Jeremiah One and Five joins team reporter Briana Jeannel for a pregame chat ahead of #LACvsSF at Levi's® Stadium.

Cracker Barrel joins Target, Bud Light and other companies facing public outcry over corporate decisions as its new logo change triggers investor unease.

The halt by one of the world’s largest couriers comes after President Trump eliminated an exemption on tariffs levied on imported goods valued under $800.